Cytochrome P450 Enzymes and Drug Metabolism in Humans

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature

Nelson, D. R., Koymans, L. M. H., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,946

Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,356

Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture.

Conney, A. H. (1982) · PubMed · Cited by 1,557

Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects

Ingelman‐Sundberg, M., Sim, S. C., Gomez, A. V., & Rodríguez‐Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,180

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

Ingelman‐Sundberg, M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500285 · Cited by 1,111

Predicting in vivo drug interactions from in vitro drug discovery data

Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 910

Cytochrome P450 Structure, Function and Clinical Significance: A Review

Palrasu, M., & Nagini, S. (2017) · Current Drug Targets · doi:10.2174/1389450118666170125144557 · Cited by 855

Inhibition and Induction of Cytochrome P450 and the Clinical Implications

Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 827

The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans

Danielson, B. S. P. P. B. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337054 · Cited by 775

Therapeutic potential of rutamarin: preclinical evidence of its biological properties through in silico, in vitro, and in vivo studies

Suhaimi, S. A., Yusof, K. M., & Saad, N. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-00945-4

The quantitative impact of metabolism‐inhibiting drugs on the occurrence of adverse drug reactions—A backward selection approach

Berres, J., Wozniak, J., Fölsch, H., Knüppel-Ruppert, A., Graeff, V., Kriegisch‐Stumpf, A., Dormann, H., Stingl, J., & Just, K. S. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70494

In Silico discovery of GES-5 inhibitors via molecular docking, molecular dynamics simulation studies, and ADMET prediction

Ghatesse, M., Charoute, H., Raoufi, A., Tabouktirt, Y., Irahal, I. N., Hmimid, F., Kabine, M., Bourhim, N., & Zouheir, Y. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.108975

Integrative Pharmacokinetic and Metabolomic Analyses Reveal the Underlying Mechanisms of Metabolic Regulation and Support the Safe Use of Oxolinic Acid in Micropterus salmoides

Yang, J., Li, M., Chen, X., Song, C., Fan, L., Qiu, L., Li, D., Xu, H., Li, T., Huang, Y., et al. (2026) · Antioxidants · doi:10.3390/antiox15030283

Advanced Cancer Drug Development through Reverse Pharmacology: Integrating Traditional Knowledge and Herbal Therapies

Anand, A., Kumar, D., Chatterjee, S., & Patel, A. K. (2026) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921420307251127050717

vToxiNet: a biologically constrained deep learning framework for interpretable prediction of drug-induced hepatotoxicityPreprint

Jia, X., Wang, T., Russo, D. P., Aleksunes, L. M., Xiao, S., & Zhu, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.708259

Integrative machine learning and structure-based computational modeling reveal germination-driven enrichment of bioactive dipeptides in pigmented rice

Guzman, C. D. I. D., Perfinian, G. C., Alseekh, S., Fernie, A. R., Tiozon, R. N., & Sreenivasulu, N. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108610

A Review of Pharmacogenetic Studies Concerning Genetics and Treatment Response in Parkinson’s Disease

Pujari, G., Neethirajan, G., Dalal, A., Kachave, R. N., Pannu, A., Lale, S. S., Tripathi, A. K., Thakur, D., Raza, M. T., Patel, N. B., et al. (2026) · BIO Web of Conferences · doi:10.1051/bioconf/202622806005 · Cited by 1

Synthesis, Biological Evaluation, and Theoretical Study of Indenoquinolinylphosphine Oxide Derivatives as Topoisomerase 1 Inhibitors and Antiproliferative Agents

Rodríguez, A. R., Formoso, E., Knudsen, B. R., Tesauro, C., Fuertes, M., & Alonso, C. (2026) · ChemMedChem · doi:10.1002/cmdc.202500751

Elucidating the mechanistic association of xylene inducing non-small cell lung cancer through network toxicology and molecular docking analysis

Chen, H., Chen, X., Lin, W., Chen, Q., Lin, R., Zhang, M., & Qi, Y. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341548

Primary Cell Isolation from Solid Tissues and Current Understanding for Their Application in Personalized Medicine and Drug Development

Berényi, E. (2026) · Biochemistry · doi:10.5772/intechopen.1011997

The Biochemical and Genetic Effects of Lavandula angustifolia and Medical Ozone Treatments on Acute Liver Toxicity

TAŞ, İ. Z., kolcuoğlu, D., Tükenmez, M., Altıner, N., Erisa, A. C. A. R., Çolak, E., Sarı, İ., & Öner, Ç. (2026) · Biochemical Genetics · doi:10.1007/s10528-026-11351-z

Molecular Epidemiological Analysis on CYP1A1 m1 (rs4646903) and m2 (rs1048943) Polymorphisms to Correlate Cancerous and Precancerous Lesions of Uterine Cervix

Venkatapathy, S., Natarajan, P. S., subramanian, S., Subramanian, M. J., & Gopinath, S. C. B. (2026) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-026-01120-6

Acute hemodynamic and autonomic modulation following beetroot and grapefruit juice consumption, alone and in combination, in adults with hypertension: A randomized crossover pilot study

Sai, A., Shetty, P., & Shetty, G. B. (2026) · Nutrition and Health · doi:10.1177/02601060261434455

QSAR and Docking Based Screeningof Pyrrolidine Derivatives as Matrix Metalloproteinase-2 Inhibitors

Yadav, R. K., Chandra, P., & Patil, V. M. (2026) · The Open Medicinal Chemistry Journal · doi:10.2174/0118741045417056260121185145

Liver-on-a-Chip: Searching for a Balance Between Biomimetics and Functionality

Murashko, A. V., Golubchikov, D. O., Smirnova, O. A., Oleynichenko, K., Nesterova, A., Vosough, M., Svistunov, A., Shpichka, A. I., & Timashev, P. (2026) · Biosensors · doi:10.3390/bios16040191

Effect of Cytochrome P450 3A4 Genetic Polymorphisms on Heme Recognition by Using Molecular Dynamics Simulations

Mizuno, A., Nakayoshi, T., Mizutani, E., Hiratsuka, M., Kato, K., & Oda, A. (2026) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b26-00029

Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma

Jung, H., Baek, G. O., Yoon, M. G., Jang, S. H., Cheong, J. Y., Kim, S. S., & Eun, J. W. (2026) · Medical Sciences · doi:10.3390/medsci14020178

Type 2 diabetes mellitus as a state of altered drug pharmacokinetic-pharmacodynamic parameters: an update on recent developments and clinical implications

Sibiya, N. H., Onyekwuluje, C., Kuretu, A., Ayodele, O., Ngcobo, N., Ngubane, P. S., & Khathi, A. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241305021 · Cited by 2

A comparative analysis of liver tissue and novel primary organoid cultures from ruminants reveals species-specific immune architecture and metabolic specializationPreprint

Garner, M. E., Price, D. R. G., McCarron, P., Bartley, D. C., Faber, M., Quinn, B., Robinson, M. W., & Smith, D. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.01.715896

Predictive Performance of Machine Learning of Herb-Drug Interactions (HDIs) Based on Cytochrome P450 Enzyme

Kantawong, K., Pravesjit, S., Cheawsuwan, T., Pravetjit, W., Yaibuates, M., & Sookying, S. (2026) · Joint International Conference on Digital Arts, Media and Technology with ECTI Northern Section Conference on Electrical, Electronics, Computer and Telecommunications Engineering (ECTI DAMT & NCON) · doi:10.1109/ectidamtncon67592.2026.11460013

Fonctions des peptides smORF Tic-Tac et Sem1 dans la reproduction et le développement chez la Drosophile

Pelletier, A. (2023) · theses.fr (ABES) · doi:10.70675/b99beb96z720ez44c5zbef1z1f9cb54576b8

A multi-approach investigation of Rigidoporus ulmarius as a promising source of nutraceutical leads against diabetes and triple negative breast cancer

Dewangan, C., Agrawal, S., & Shahi, S. K. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00617-4

Synthesis, Antitubercular Activity, and Computational Characterization of Novel Phenylpyrazole‐Isoniazid Derivatives

Carrasco, F. C., Hernández, W., Dávalos, J. Z., Mosquera, J., Chupayo, O., Sivipaucar, N. E., Tamayo, J., Carrasco-S, E., Coronel, J., Yáñez, O., et al. (2026) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/adpp/2155127

Structural context of NADPH-cytochrome P450 reductase mutations that alter cytochrome P450 1A2 substrate regioselectivity

Burris‐Hiday, S. D., Esteves, F., Kranendonk, M., & Scott, E. E. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100300

Bibliometric Analysis of Cubebenes and Related Sesquiterpenes: Natural Occurrence, Biosynthesis, Pharmacological Activities, and In‐Silico‐Based Future Therapeutic Potential

Boualam, K., Ortaakarsu, A. B., Khatib, S., Farag, M. A., & Sobeh, M. (2026) · eFood · doi:10.1002/efd2.70128

Particulate matter induced cell death: Current understanding of molecular drivers that lead to lung damage

Das, D. N., & Mitroo, D. (2026) · Next research. · doi:10.1016/j.nexres.2026.101769

Prevalence and correlates of pharmacotherapy metabolized by CYP2C19, CYP2C9, CYP2D6, and UGT1A1 in the population sample

Anfinogenova, Y., Stepanov, V. A., Kuznetsova, A. D., Chesalov, N. P., Popov, S. V., & Repin, A. N. (2026) · Personalized Medicine · doi:10.1080/17410541.2026.2659007

Organophosphorus pesticide and nerve agent surrogate metabolism by human CYP3A4Preprint

Shriwas, P., Noonchester, A. M., Scarpitti, B. T., Revnew, A., Lane, T. R., Ekins, S., Hadad, C. M., & McElroy, C. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.23.720309

Intracellular Heme‐Containing Enzyme in Neurodegenerative Disorders

Tyagi, S. J., & Sharma, K. K. (2026) · Macromolecular Symposia · doi:10.1002/masy.70320

Revolutionizing genomic medicine with artificial intelligence and data analytics

Patra, P. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27638-5.00013-4

Adaptive evolution and transcriptional plasticity of the cytochrome P450 superfamily underpin sulfide tolerance in the Urechis unicinctus

Wang, Q., Han, M., Shi, Y., Liang, Q., 庞纪彩, Yu, Z., Song, P., & Wang, X. (2026) · Journal of Experimental Marine Biology and Ecology · doi:10.1016/j.jembe.2026.152199

Structure-Based Drug Design to Identify Potent, Selective, and Orally Available Cyclin-Dependent Kinase 9 Inhibitors for the Treatment of Castration-Resistant Prostate Cancer

Liu, W., Wu, L., Rong, Z., Zou, L., Huang, Y., Liu, W. T., Li, C., Liu, X., Zhou, K., Hu, K., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00498

CypGEM: A Geometry-Aware and Edge-Enhanced Graph Transformer Model for Predicting Sites of Metabolism Mediated by Cytochromes P450

Zhang, Y. X., Yang, Y., Zhan, M., Liu, G., Tang, Y., & Li, W. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c01181

Inhibitory effects of polyphyllin VII on cytochrome P450 2C19, 2D6, 2E1, and 3A4 in human liver microsomes

Guo, Z., An, X., & Liu, H. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110842

Eco-Friendly Ultrasound-Assisted Synthesis and Comprehensive Analysis of Spiropyranopyrazole Derivatives: A DMAP-Catalyzed One-Pot Approach with Spectroscopic and Computational Insights

Giri, M., Bharti, R., Thakur, A., Verma, M., Sharma, R., & Bansal, R. (2026) · Current Organocatalysis · doi:10.2174/0122133372399786251103093001

Keeping Wavering Bonds: Deactivation-Induced Signaling by Reactive Electrophiles

Long, M. J. C., Karakoç, Y., & Aye, Y. (2026) · Biochemistry · doi:10.1021/acs.biochem.6c00173

Integrative In Silico and In Vitro Evaluation of Vialox and Leuphasyl Pentapeptides for Antiaging Applications

Akhan, D., Bıçak, B., Kurtur, O. B., Budama‐Kilinc, Y., & Kecel‐Gunduz, S. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502546

Early adverse drug reactions to sertraline in adolescents with a depressive episode: assessment of associations with CYP2C19*2, *17 in observational study

Ivashchenko, D. V., Sobur, V. V., Grass, S. V., Basova, A. Y., Викторович, Ш. П., Shubin, A. V., Deitch, R. V., Николаевна, Т. С., Korsakov, I. N., Mirzaev, K. B., et al. (2026) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn18133

The biology, function, and applications of exosomes as novel biomarkers for in-vivo drug exposure variability

Yang, Y., Yu, Z., Dou, W., Shi, S., Zhang, B., & Liu, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1822691

Effects of microgravity on human physiology

Cools, B., Smith, M. B., Boutouyrie, P., Ciccone, V., Meulemeester, P. D., Fernandez‐Gonzalo, R., Frippiat, J., Oliver, B. G. G., Gentile, S., Goswami, N., et al. (2026) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2026.05.004

In silico study of bioactive compounds from Morinda lucida as potential inhibitors of Plasmodium falciparum glutathione reductase using PASS prediction, ADMET analysis, molecular docking, DFT, and molecular dynamics simulations

Olarinoye, E. F., Latona, D. F., Atere, T. G., Asibor, Y. E., & Semire, B. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100375

6PPD metabolic activation by CYP3A initiates cytotoxicity in mouse primary hepatocytes

Sun, Y., Zheng, J., Zhao, Y., Li, W., Hu, Z., Peng, Y., & Zheng, J. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04438-4

Discovery of Potential Antihypertensive Agents from the Marine Microalga Phaeodactylum tricornutum Through Metabolite Profiling and In Silico Analysis

Guzmán-Rodríguez, M. E., Valdez-Flores, M. A., Ayón-Fernandez, C., Ordaz-Ortíz, J. J., Guadrón‐Llanos, A. M., Magaña‐Gómez, J. A., la Herrán-Arita, A. K. D., Camberos-Barraza, J., Picos-Cárdenas, V. J., Osuna‐Ramos, J. F., et al. (2026) · Scientia Pharmaceutica · doi:10.3390/scipharm94020043

Safety and tolerability of different DAAs regimens

Al-Naaman, K., & Al‐Sinani, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41363-6.00010-x

In Silico Discovery and Preliminary In Vitro Evaluation of a SETDB1-Related Candidate Compound Associated with Early Osteogenic Effects

Li, Z., Zhang, X., Chen, S., Meng, Q., Lv, Z., Niu, Z., Li, J. M., & Chen, X. (2026) · Future Pharmacology · doi:10.3390/futurepharmacol6020031

Aflatoxin B1 and food safety: Mechanisms of action associated to Hepatocellular Carcinoma

Zamudio, M., & Balleza, D. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-04978-4

In Silico Pharmacokinetic Profile and Antimalarial Efficacy of 3‐Chloro‐4‐(4‐Chlorophenoxy)Aniline

Waithera, M. W., Kimani, S. K., Njoroge, S., Nyahanga, T., & Kinyua, J. K. (2026) · Biochemistry Research International · doi:10.1155/bri/6509347

In Silico designing of piperazine-sulfathiazole derivatives: A computational approach for novel anti-microbial agents

Aggarwal, S., & Kaur, P. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.102476

Current Regulations and Clinical Applications of Nutraceuticals

Lim, K. G., Alam, N. N., & Muthuraman, A. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813994126010016

Polar solvation influence on the structure and bonding, and the potential antiviral inhibitory activity of diterpenoid obtained from Jatropha multifida plant

Willie, P. O., Oladipo, P., Chioma, O. V., Chinyere, C. P., Pascal, O. C., Ekpong, B. O., & Edeghor, U. O. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100443

Protective Role of Ajmalicine Against Benzo(a)pyrene-induced Lung Cancer Through Regulation of Inflammatory and Oxidative Pathways

Yan, H., Yu, X., Su, Y., Geng, L., & Pei, Y. (2026) · Pharmacognosy Magazine · doi:10.1177/09731296261447607

Biochemical parameters in toxicological studies in Africa: an update for their significance, principles of methods, data interpretation, and use in plant screenings

Dzoyem, J. P., Adebayo, S. A., & Kuete, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45179-9.00027-6

Synthesis, spectroscopic characterization, DFT analysis, and EGFR docking studies of novel Schiff base derivatives

Fatima, M., Aiman, Ahmad, F., Fatima, A., & Mujtaba, M. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00771-w

Investigation of Pharmacogenomic Variants in the CYP (P450) Family in Native American Populations of the Brazilian Amazon

de Freitas, L. M., Rodrigues, J. C. G., de Moraes, F. C. A., Monte, N., da Costa, A. C. A., Coelho, R. D. C. C., Aguiar, K. E. C., dos Santos, A. M. R., Guerreiro, J. F., Ribeiro‐dos‐Santos, Â., et al. (2026) · International Journal of Genomics · doi:10.1155/ijog/5804093

Effects of Elevated Oxytetracycline on Cytochrome P450 and Immune-Related Gene Expression and Histopathological Alterations in Olive Flounder, Paralichthys olivaceus

Na, H. J., Lee, G. B., Kong, H. J., Kim, J.-W., & Hwang, S. D. (2026) · Animals · doi:10.3390/ani16121853

In silico Investigation of Electrochemical Degradation and Toxicity Evolution of Pyridine Compounds in Aqueous Media

Choudhary, N., Kaur, J., & Kumar, A. (2026) · Biointerface Research in Applied Chemistry · doi:10.33263/briac163.074

Pharmacogenomics and Epigenetic Regulation Transforming Pediatric Precision Therapeutics

Satyam, S. M., Prabhakar, S., Densil, T., Mohammed, H. T., Kumari, R., El-Tanani, M., Rehman, A., Kharoufeh, A., Dalbah, M., & Eltrabishi, M. T. Z. M. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16060329

Influence of Plant Secondary Metabolites on intake, Detoxification Costs, and Microbial Communities in Deer

Anderson, K. L., Shipley, L. A., Staudenmaier, A. R., Galla, S. J., & Forbey, J. S. (2026) · Journal of Chemical Ecology · doi:10.1007/s10886-026-01729-z

A framework for optimized reaction phenotyping of the seven major hepatic P450 isoforms in human liver microsomes using six mechanism-based inactivators and one reversible inhibitor

Wang, T., Jacob, K., Raymond, K. G., & Taub, M. E. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100349

Acorus calamus L. enables tetracycline and sulfamethoxazole phytoremediation via host transcriptional–metabolic adaptation and changes in vertically transmitted endophyte populations

Gong, Y., Liu, H., Jiang, Y., Wang, Y., & Qi, Y. (2026) · Environmental Research · doi:10.1016/j.envres.2026.125083

Drugs and the liver

Lambarth, A. T., & Threapleton, C. J. (2026) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2026.06.001

In silico insights into pyrazolochalcones: molecular modeling and design of novel antagonists of estrogen receptor for breast cancer intervention using QSAR modeling, molecular docking, molecular dynamics, DFT, and ADMET studies

Ameji, P. J., Shtaiwi, A., & Adnan, R. (2026) · Chemical Papers · doi:10.1007/s11696-026-05174-w

New insight into the redox activity of niclosamide, an anthelmintic drug, and some of its metabolites. A new perspective on toxicity and detoxification

Nematollahi, D., & Rahmati, H. K. (2026) · RSC Advances · doi:10.1039/d6ra02391f

Xenobiotics Induced Liver Toxicity

Gjorgjievska, K., Pavlovska, K., Zendelovska, D., Atanasovska, E., & Petrushevska, M. (2026) · PRILOZI · doi:10.2478/prilozi-2026-0024

Computational modeling of selected phytochemicals from Reevesia formosana: mechanistic insights into their potential against lung cancer

Hùng, N. Đ. (2026) · Biophysical Bulletin · doi:10.26565/2075-3810-2026-56-07

Synergistic integration of forensic transcriptome and microbiome: A robust multi-marker strategy combined with machine learning for accurate body fluid identification

Wang, X., Liang, Q., Yuan, X., Cai, M., & Zhu, B. (2026) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2026.103583

Investigation of the Potential Neuroprotective Mechanisms of Acalypha indica Against Alzheimer’s Disease by Integrated Bioinformatics Analysis

Nguyen, L. T. H., Nguyen, H. T., & Nguyen, T. U. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146196

Evaluation of AlphaFold3 for Predicting Human Heme-Binding Protein Structures

Nam, K. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146278

Intestinal Microbiota and Metabolomics Analysis of Asian Swamp Eel ( Monopterus albus ) With Hemorrhagic Septicemia Caused by Aeromonas veronii

Feng, Z., Yang, Y., Ayana, G. U., Zhao, Y., Wang, Y., Zhou, W., & Zhang, Q. (2026) · Journal of Fish Diseases · doi:10.1111/jfd.70244

Computational and experimental evaluation of Pisolithus arhizus metabolites targeting major efflux pumps of mastitis-associated Staphylococcus aureus

Gul, H., Zahra, I., Nasreen, Z., Khan, H. A., Naeem-ul-Hassan, M., Ahmad, N., Assad, N., Kifle, D. R., & Garrido-Palazuelos, L. I. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354013

Heat-Inactivated Lactiplantibacillus plantarum H6 Potentiates Low-Dose Simvastatin Efficacy Against Hypercholesterolemia in Mice Through Gut Microbiota Modulation

Li, Y., Zhou, G., Yin, C., Yu, X., Ma, X., Ren, D., & Leng, Y. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11141-4

Pulmonary Drug Delivery in the Era of Nanomedicine: From Biological Barriers to Artificial Intelligence-Driven Optimization

Alradwan, I. A., Allabban, S. A., Aleissa, A. S., Alqahtani, N. M., Alghamdi, H. A., Fayez, N. A., Alshabibi, M. A., Tawfik, E. A., Almughem, F. A., & Alshehri, A. A. (2026) · Pharmaceuticals · doi:10.3390/ph19071095 · Cited by 1

Unveiling nicotiflorin analogs with improved oral drug-like metrics as candidates for the development of dengue virus NS2B-NS3 protease inhibitors: An in silico study

Awuni, E. (2026) · Journal of Chemical Research · doi:10.1177/17475198261469655

Phytotoxicity of pharmaceuticals and personal care products

Singh, S., & Daverey, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33110-7.00007-9

Sediment mutagenicity in East Taihu Lake and Yangcheng Lake, China: Comparing rat-derived and human-relevant S9 fractions in the Ames fluctuation testPreprint

Xue, F., Reichstein, I. S., Jia, Y., Yin, D., Wu, L., Schiwy, A., & Hollert, H. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7151177

Molecular docking analysis of curcumin and its analogs as an antiviral against NSP4 protein of porcine reproductive and respiratory syndrome virus

Pandarangga, P., Amalo, M. E., Liu, A., Dangur, F. A., & Laut, M. M. (2026) · Open Veterinary Journal · doi:10.5455/ovj.2026.v16.i7.62

Novel 3,3′-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis

Ergüç, E. İ., Entezari, B., Şirinzade, H., Süzen, S., Akdemir, A., Erdogan, O., & Gürer-Orhan, H. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00625-x

Integrative Network Pharmacology and ADMET Modeling Reveal the Multitarget Therapeutic Potential of Geraniol

da Costa, M. H. D. A., Filgueiras, L. A., & Mendes, A. N. (2026) · Drugs and Drug Candidates · doi:10.3390/ddc5030041

Machine Learning in the Optimization of Pharmacokinetic Parameters

Hossain, M. M., Pore, S., Banerjee, A., & Roy, K. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837070206-00430

Inhibitory effects of hinokiflavone on human liver cytochrome P450 enzymes

Han, N., & Jiang, D. (2026) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2026.102080

Recent applications of liquid chromatography tandem mass spectrometry at various stages of drug development

Gagare, S. S., Thorat, V. B., & Jain, A. S. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-01011-9

Rational Design and Computational Analysis of Covalent Benzofuran Fluorophosphonate Inhibitors in a Heme-Depleted Model of CYP1A1

Latkovic, F., & Ricco, F. D. (2026) · International Journal of Organic Chemistry · doi:10.4236/ijoc.2026.163005

The Paradigm Shift in Oncology

Sani, A., Makki, H. H., & Kugedera, A. T. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-9848-8.ch001

Beyond one drug–one target: AI-guided discovery of multi-target antiviral therapeutics

Gupta, V., Sharma, S., Abbot, V., Bhatia, R., Choudhary, N., & Kumar, D. (2026) · Frontiers in Virology · doi:10.3389/fviro.2026.1853552

Nanoparticles and their significant risks: a comprehensive review of toxicological and regulatory perspectives

Skonieczna, B., Nazarko, N., Godlewska, E., Wasiluk, N., Czech, E. K., Wilczewska, A. Z., Regulska, E., Car, H., & Niemirowicz-Laskowska, K. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04801-8

Drug Metabolism

Silverman, R. B., Xue, F., & Juncosa, J. I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15862-9.00011-4

CYP450 Gene Variations and Their Implications for Drug Response: A Pharmacogenomic Review

Siahaan, A. E. F., Suparningtyas, J. F., Sakinah, I. F., Tosuli, K., Azzura, A., Siahaan, A. E. F., ⁠Sabrina, Febriani, N., Purek, ⁠. B. O., Aileen, K., et al. (2026) · Journal Of Tropical Pharmacy And Chemistry · doi:10.30872/jtpc.v10i2.434

Implementation of a computational medical assemblage heuristic to improve rational design of phytomedicines for safety, efficacy and regulatory approval

Wooton, B. T., Rice, B. G., Howard, J., Jansen, C., Flynn, C., Adra, C. N., Kodaira, E., Small-Howard, A. L., Stokes, A. J., & Turner, H. C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1726867

Investigation of Thymoquinone as an Inhibitor of CYP2C8/EET Axis

Dhiman, S., Manhas, D., Jamwal, A., Singh, A., Kumar, V., Vij, B., Ojha, P. K., Singh, S. K., Ahmed, Z., & Nandi, U. (2026) · ChemBioChem · doi:10.1002/cbic.202600003

The Enzyme-Bag Platform for Cytochrome P450 Biotransformation and High-Throughput Drug Metabolism Screening

Durairaj, P. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5190-2_9

The role of deuteration in enhancing anticancer therapy: Mechanisms, pharmacokinetics, and clinical updates

Kennedy, M. M. R., Ramasamy, S., & Enoch, I. V. M. V. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115201

Phytochemical profiling, safety assessment, and pharmacological validation against pain and inflammation of Teucrium chamaedrys L. crude extract

Baali, F., Djemouaı, N., Bouafia, Z., Righi, N., Deghima, A., Elfalleh, W., & Bendif, H. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122283

Visual screening for CYP3A4 inhibition induced by traditional Chinese medicine injections at the aqueous/liquid crystal interface

Chen, J., Pan, Q., Huang, S., Cao, J., Zhang, M., Liu, M., Liu, Z., Jin, M., & Shui, L. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2026.140684

Anti-Inflammatory Potential of n-Hexane Extract From Mesua nagassarium Stem Bark: An Experimental and In Silico Study

Siddika, F., Chowdhury, S. I., Sharmin, T., Das, S., Alam, M. R., Hossain, M. A., Mouri, N. J., Sarker, M. F., Chowdhury, D. U. S., Mostafa, M., et al. (2026) · Natural Product Communications · doi:10.1177/1934578x261479028

Revisiting multicomponent Doebner and Povarov quinoline synthesis for modern-day drug-discovery

Winkelhake, C. M., Hartley, M., Yadav, P., & Sintim, H. O. (2026) · Organic & Biomolecular Chemistry · doi:10.1039/d6ob00871b

Pharmacogenetic aspects of drug interactions in stroke patients (using the CYP2C9 gene as an example)

Vorobyeva, N. A., Sharapova, S. A., Vorontsova, A. S., & Kharkova, O. A. (2026) · Pharmacogenetics and Pharmacogenomics · doi:10.37489/2686-8849-0015

RingKin: portraying the vast macrocyclic chemical universe surrounding kinase drugs

Diao, Y., Hu, F., Jiang, W., Hu, Y., Ma, S., Wu, D., Tong, L., Xiang, S., Chen, C., Li, Z., et al. (2026) · Chemical Science · doi:10.1039/d6sc04105a

A review on the toxicity and safety assessment of herbal natural products

Adesina, T. P. (2026) · Toxicology Research · doi:10.1093/toxres/tfag066

Cytochrome P450 Polymorphisms

Zanger, U. M. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm009 · Cited by 2

Cytochrome P450

Bhatia, K. S., Mahesh, A. N., & Bhatt, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00696-5 · Cited by 2

Drug Response Heterogeneity and the Genetic Variability of Cytochrome P450–Metabolizing Enzymes

Zhou, S.-F., & Sneed, K. (2014) · doi:10.1201/b15465-16 · Cited by 1

Pharmacogenetics of the Cytochrome P450 Enzyme System: Review of Current Knowledge and Clinical Significance

Al‐Omari, A., & Murry, D. J. (2007) · Journal of Pharmacy Practice · doi:10.1177/0897190007304821 · Cited by 43

Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes

Song, Y., Li, C., Liu, G., Liu, R., Chen, Y., Li, W., Cao, Z., Zhao, B., Lu, C. C., & Liu, Y. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01001-5 · Cited by 115